the UAE argued the court had no jurisdiction.

“YouTube should reverse this dangerous policy change and update its ‘Hate Speech’ policy to expressly include gender identity and expression as a protected characteristic,” the report says.GLAAD’s report makes policy recommendations for protecting LGBTQ users, though it’s unclear if the platforms will take these up, given that many have rolled back such protections. For instance, GLAAD says platforms should protect LGBTQ people from hate, harassment and violence, prohibit targeted misgendering and “deadnaming” of transgender users and explain steps it takes to stop wrongfully removing or demonetizing legitimate accounts and content related to LGBTQ topics.

ST. PAUL, Minn. (AP) — Democratic Minnesota Attorney Generalfiled a preemptive lawsuit Tuesday against Republican President Donald Trump seeking to block his administration from acting against Minnesota in the way it’sunder a federal push to ban transgender athletes from girls and women’s sports.

“Minnesota brings this lawsuit to stop President Trump and his administration from bullying vulnerable children in this state,” Ellison said at a news conference, quoting the opening line from the lawsuit naming Trump and his attorney general, Pam Bondi.When Bondi announced the administration’s lawsuit against Maine last week, she warned that Minnesota and California could be next. The administration’s lawsuit followed weeks of feuding between Trump and Democratic Gov. Janet Mill of Maine that led to a clash at the White House when she told Trump, “We’ll see you in court.”

With this case, Ellison is trying to beat Trump and Bondi to the courthouse.

The federal lawsuit asks the court to declareGenetic testing companies such as GeneDx have made some headway in screening more people of diverse backgrounds, but inequities remain.

For example, comprehensive data about cystic fibrosis is scarce among African populations – affecting people who live on the continent as well as those who trace their ancestry there.Black cystic fibrosis patients are more likely than their white counterparts to be among the 10% who don’t benefit from modulator therapies.

While there’s little chance of changing market dynamics, researchers said, one solution is to develop “mutation agnostic” gene therapies targeting all patients with a disease. This approach is being tried in diseases of the retina as well as cystic fibrosis.“There’s a huge push to develop these therapies,” said Dr. Garry Cutting of the Johns Hopkins Cystic Fibrosis Center.